These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15326485)

  • 1. TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions.
    Mori S; Matsuzaki K; Yoshida K; Furukawa F; Tahashi Y; Yamagata H; Sekimoto G; Seki T; Matsui H; Nishizawa M; Fujisawa J; Okazaki K
    Oncogene; 2004 Sep; 23(44):7416-29. PubMed ID: 15326485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury.
    Yoshida K; Matsuzaki K; Mori S; Tahashi Y; Yamagata H; Furukawa F; Seki T; Nishizawa M; Fujisawa J; Okazaki K
    Am J Pathol; 2005 Apr; 166(4):1029-39. PubMed ID: 15793284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts.
    Furukawa F; Matsuzaki K; Mori S; Tahashi Y; Yoshida K; Sugano Y; Yamagata H; Matsushita M; Seki T; Inagaki Y; Nishizawa M; Fujisawa J; Inoue K
    Hepatology; 2003 Oct; 38(4):879-89. PubMed ID: 14512875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis.
    Yamagata H; Matsuzaki K; Mori S; Yoshida K; Tahashi Y; Furukawa F; Sekimoto G; Watanabe T; Uemura Y; Sakaida N; Yoshioka K; Kamiyama Y; Seki T; Okazaki K
    Cancer Res; 2005 Jan; 65(1):157-65. PubMed ID: 15665291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells.
    Brown JD; DiChiara MR; Anderson KR; Gimbrone MA; Topper JN
    J Biol Chem; 1999 Mar; 274(13):8797-805. PubMed ID: 10085121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway.
    Rousse S; Lallemand F; Montarras D; Pinset C; Mazars A; Prunier C; Atfi A; Dubois C
    J Biol Chem; 2001 Dec; 276(50):46961-7. PubMed ID: 11598109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
    Hayashida T; Decaestecker M; Schnaper HW
    FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription.
    Engel ME; McDonnell MA; Law BK; Moses HL
    J Biol Chem; 1999 Dec; 274(52):37413-20. PubMed ID: 10601313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
    Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
    Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
    Alvarez J; Serra R
    Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
    Schedlich LJ; Yenson VM; Baxter RC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
    Wakahara K; Kobayashi H; Yagyu T; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    J Cell Biochem; 2004 Oct; 93(3):437-53. PubMed ID: 15372629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo.
    Kamaraju AK; Roberts AB
    J Biol Chem; 2005 Jan; 280(2):1024-36. PubMed ID: 15520018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor β-mediated site-specific Smad linker region phosphorylation in vascular endothelial cells.
    Kamato D; Rostam MA; Piva TJ; Babaahmadi Rezaei H; Getachew R; Thach L; Bernard R; Zheng W; Little PJ; Osman N
    J Pharm Pharmacol; 2014 Dec; 66(12):1722-33. PubMed ID: 25316549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity.
    Pessah M; Prunier C; Marais J; Ferrand N; Mazars A; Lallemand F; Gauthier JM; Atfi A
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6198-203. PubMed ID: 11371641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel transcriptional factor with Ser/Thr kinase activity involved in the transforming growth factor (TGF)-beta signalling pathway.
    Ohta S; Takeuchi M; Deguchi M; Tsuji T; Gahara Y; Nagata K
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):395-404. PubMed ID: 10947953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.